Submission Details
| 510(k) Number | K231424 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 17, 2023 |
| Decision Date | December 13, 2024 |
| Days to Decision | 576 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K231424 is an FDA 510(k) clearance for the HeartBeam AIMIGo(TM) System, a Electrocardiograph, Ambulatory (without Analysis) (Class II — Special Controls, product code MWJ), submitted by Heartbeam, Inc. (Santa Clara, US). The FDA issued a Cleared decision on December 13, 2024, 576 days after receiving the submission on May 17, 2023. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.2800.
| 510(k) Number | K231424 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 17, 2023 |
| Decision Date | December 13, 2024 |
| Days to Decision | 576 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | MWJ — Electrocardiograph, Ambulatory (without Analysis) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.2800 |